HUENENBERG, Switzerland--(BUSINESS WIRE)--The Alcon Independent Director Committee (the “Committee”) noted today that Alcon once again delivered strong earnings in the second quarter of 2010. Alcon’s 2Q 2010 Adjusted EPS of $2.22 per share represented a year-over-year growth rate of 14.4% and exceeded Wall Street’s mean consensus estimate of $2.03 per share by 9.4%. Alcon’s strong EPS growth was driven by an 11.3% increase in organic sales resulting, in part, from a 22.3% increase in advanced technology intraocular lens sales, a 17.2% increase in glaucoma sales and a 24.2% increase in emerging market sales.
